Table 4 Follow up, adverse events and mortality data
Diagnostic group | Resting precapillary PH (n = 28) | Exercise precapillary PH (n = 13) | Resting postcapillary PH (n = 7) | Exercise postcapillary PH (n = 12) | Exercise postcapillary out-of-proportion PH (n = 14) | No PH (n = 27) |
|---|---|---|---|---|---|---|
Follow-up days, n | 1,080 (246; 1231) | 1,031 (366; 1346) | 1,080 (279; 1290) | 718 (321; 1440) | 1,112 (542; 1332) | 714 (282; 1241) |
Death, n | 1 | 1 | 1 | 1 | 0 | 2 |
Lung transplantation, n | 3 | 0 | 0 | 0 | 0 | 0 |
Pulmonary endarterectomy, n | 2 | 1 | 0 | 0 | 0 | 0 |
Adverse events at RHC, n | 0 | 0 | 0 | 0 | 0 | 0 |